Trade Summary

4 days ago, Espinoza Octavio, serving as CFO at Ligand Pharmaceuticals Inc (LGND), sold 3,057 shares at $225.00 per share, for a total transaction value of $687,825.00. Following this transaction, Espinoza Octavio now holds 21,010 shares of LGND.

This sale represents a 13.00% decrease in Espinoza Octavio's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 11, 2026 and publicly disclosed via SEC Form 4 filing on Friday, March 13, 2026, 2 days after the trade was made.

Ligand Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.